BioArctic AB (publ) reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was SEK 437.59 million compared to SEK 1,289.61 million a year ago. Net income was SEK 212.39 million compared to SEK 1,021.47 million a year ago.

Basic earnings per share from continuing operations was SEK 2.4 compared to SEK 11.55 a year ago. Diluted earnings per share from continuing operations was SEK 2.39 compared to SEK 11.53 a year ago.